Selventa

The company is developing a test to predict RA patients' response to various drugs beginning with anti-TNF therapy, which it highlighted in a recent publication.

Title: Methods and compositions for base calling nucleic acids
US Patent Number: 8,612,161

YarcData, a spinoff from supercomputing firm Cray, and Selventa, a bioinformatics firm that serves the pharmaceutical industry, have signed an agreement that allows the latter to run its data analysis engine on Urika, YarcData's graph analytics appliance (

This week, the Linux Foundation, a non-profit consortium that supports the Linux operating system, announced that the publicly available version of Selventa's Biological Expression Language, OpenBEL, is now one of its collaborative projects.

Epizyme, Abbott Developing CDx for Mixed Lineage Leukemia Drug
Epizyme and Abbott announced they are working together to develop a molecular diagnostic to accompany its investigational treatment for mixed lineage leukemia, EPZ-5676.

NEW YORK (GenomeWeb News) – Seegene and Selventa have entered into a collaborative agreement to develop molecular diagnostic products for "underserved markets" including autoimmune disease, cancer, and infectious diseases, the companies said today.

This week, Cambridge Mass.-based Selventa provided new details about its plans to put its informatics knowhow to use in developing a diagnostic tool for autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease.

Dotmatics has hired Mariana Vaschetto to serve as vice president of business development and marketing for Europe, Middle East, Africa, and Latin America.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Selventa today announced a research agreement with Janssen Research & Development in immunological diseases.

US Patent 8,090,543. Computer algorithm for automatic allele determination from fluorometer genotyping device. Inventor: Stephen Glanowski, Jeremy Heil, Emily Winn-Deen, Ivy McMullen. Assignee: Applied Biosystems (Life Technologies)

Pages

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.